InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Monday, 04/03/2017 9:51:48 AM

Monday, April 03, 2017 9:51:48 AM

Post# of 461398
273, 371, 141 --the order given for new MOA in PR:
371 showed results again in late stage AD in the well designed pre-clinical .... this is important for a few reasons. First, late stage is hard to treat as neurone have died in large numbers; and second it shows any pharma trying to copy 273 MOA that 371 (with full IP) is coming...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News